Metabolites Associated with Polygenic Risk of Breast Cancer

Elizabeth Samuels,Jaclyn Parks,Jessica Chu,Treena McDonald,John Spinelli,Rachel A. Murphy,Parveen Bhatti
DOI: https://doi.org/10.3390/metabo14060295
IF: 4.1
2024-05-24
Metabolites
Abstract:While hundreds of germline genetic variants have been associated with breast cancer risk, the mechanisms underlying the impacts of most of these variants on breast cancer remain uncertain. Metabolomics may offer valuable insights into the mechanisms underlying genetic risks of breast cancer. Among 143 cancer-free female participants, we used linear regression analyses to explore associations between the genetic risk of breast cancer, as determined by a previously developed polygenic risk score (PRS) that included 266 single-nucleotide polymorphisms (SNPs), and 223 measures of metabolites obtained from blood samples using nuclear magnetic resonance (NMR). A false discovery rate of 10% was applied to account for multiple comparisons. PRS was statistically significantly associated with 45 metabolite measures. These were primarily measures of very low-density lipoproteins (VLDLs) and high-density lipoproteins (HDLs), including triglycerides, cholesterol, and phospholipids. For example, the strongest effect was observed with the percent ratio of medium VLDL triglycerides to total lipids (0.53 unit increase in mean-standardized ln-transformed percent ratio per unit increase in PRS; q = 0.1). While larger-scale studies are needed to confirm these results, this exploratory study presents biologically plausible findings that are consistent with previously reported associations between lipids and breast cancer risk. If confirmed, these lipids could be targeted for lifestyle and pharmaceutical interventions among women at increased genetic risk of breast cancer.
biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between polygenic risk score (PRS) and breast - cancer - related metabolites. Specifically, the researchers hope to analyze the genetic data and metabolomics data of 143 female participants without cancer, reveal the metabolite changes related to the polygenic risk of breast cancer, and thus provide clues for further understanding the molecular mechanisms of breast cancer. The focus of the study is to determine which metabolites are significantly associated with PRS and explore the potential roles of these metabolites in the occurrence of breast cancer. ### Main research contents: 1. **Research background**: - Although hundreds of genetic variants related to breast cancer risk have been discovered, the specific impact mechanisms of most variants on breast cancer are still unclear. - Metabolomics may provide valuable insights into explaining how these genetic variants affect breast cancer risk. 2. **Research methods**: - **Research subjects**: 143 female participants without cancer. - **Data sources**: Use nuclear magnetic resonance (NMR) technology to obtain the measured values of 223 metabolites from blood samples. - **Genetic risk score (PRS)**: PRS constructed based on 266 single - nucleotide polymorphisms (SNPs). - **Statistical analysis**: Evaluate the association between PRS and metabolite measured values through linear regression analysis, and apply the Benjamini and Hochberg method to control the false discovery rate (FDR) of multiple comparisons at 10%. 3. **Main results**: - PRS is significantly associated with the measured values of 45 metabolites (q ≤ 0.1). - These significantly associated metabolites are mainly related to very - low - density lipoprotein (VLDL) and high - density lipoprotein (HDL), including triglycerides, cholesterol and phospholipids. - For example, the proportion of medium - VLDL triglycerides in total lipids has the strongest association with PRS (for each unit increase in PRS, the average standardized log - transformed percentage increases by 0.53 units). - Most VLDL - related metabolites are positively correlated with PRS, while most HDL - related metabolites are negatively correlated with PRS. 4. **Discussion**: - The research results indicate that the changes of these lipids may be involved in the mechanism of polygenic risk of breast cancer. - The negative correlation with HDL cholesterol levels is consistent with previous research results, that is, HDL cholesterol levels are usually negatively correlated with breast cancer risk. - This study is the first to integrate metabolomics and genomics data to reveal the potential mechanisms of polygenic risk of breast cancer, providing preliminary clues for future large - scale studies. ### Conclusion: This study analyzed the relationship between breast cancer polygenic risk score and metabolites and found a variety of metabolites significantly associated with PRS, especially VLDL - and HDL - related lipids. These findings provide a new perspective for understanding the molecular mechanisms of breast cancer and may provide targets for future prevention and intervention measures. However, due to the small sample size, larger - scale studies are needed to further verify these results.